Three specialists discuss how new technologies could soon be utilized in the field of seizure prediction and detection to improve patient care.
Predicting and detecting seizures: can digital health technologies help clinicians up their game?
Prof. Brinkmann has disclosed that he is/was a consultant/advisor for Otsuka Pharmaceuticals Co., Ltd., that he is/was a research/grant recipient from the Epilepsy Foundation of America, and that he owns royalties/patents for Cadence Neuroscience Inc.
Prof. Cook has disclosed that he owns royalties/patents/stocks for Epi-Minder Pty. Ltd. and Seer Medical Pty. Ltd., and that he has an employment affiliation with Epi-Minder Pty. Ltd. and Seer Medical Pty. Ltd.
Prof. Rubboli has disclosed that he is/was on a speaker’s bureau for Arvelle Therapeutics International Gmbh, Biocodex S.A., Eisai Co., Ltd. and UCB (Union Chimique Belge) and that he is/was a consultant/advisor for Arvelle Therapeutics International Gmbh, Biocodex S.A., Eisai Co., Ltd. and UCB (Union Chimique Belge).